3 Dividend Stocks For Reliable Income When Cash Rates Feel Less Rewarding
Kaspi.KZ KSPI | 0.00 |
With central banks holding interest rates at restrictive levels, government bond yields set the tone for income investors. Cash and short term debt now feel less rewarding once inflation and tax are factored in. Reliable dividends above 5% suddenly look more appealing as a way to target real income. This article highlights three stocks from the Dividend Powerhouses screener that offer high yields with coverage and stability.
The three stocks highlighted next are just a starting sample from this idea. The full screen surfaced 1,858 more companies with equally compelling dividend narratives that are not covered here. To identify, compare and analyze the highest conviction income opportunities, go straight to the Dividend Powerhouses (3%+ Yield) screener.
CSL (ASX:CSL)
CSL is a global biopharma group that develops and manufactures plasma therapies, vaccines and treatments for iron deficiency and kidney disease. Its CSL Behring segment is the powerhouse, generating about US$10.9b in revenue, with Seqirus flu vaccines at roughly US$2.2b and Vifor at about US$2.4b. The company is a large cap player with a market value around A$65.9b.
Income focused investors may be drawn to CSL because it combines a 3% yield with exposure to critical therapies where patients often have limited alternatives. Forecast earnings growth of 34.4% a year sits alongside recent profit pressure, a large one off loss of US$2.1b and weaker dividend coverage, so the picture is not straightforward. Add in high debt levels, a lower 9.1% net margin and governance turnover and you have a high quality healthcare business that rewards you for doing deeper homework before deciding if the current reset in expectations is an opening or a warning sign.
CSL’s reset in expectations could be masking a very different story for future earnings and dividends. Before you decide where you stand on that 3% yield, unpack the 2 key rewards and 4 important warning signs
Build your own dividend powerhouse shortlist
CSL and the two other stocks in this article all came from a single Simply Wall St screener, but the real edge is in creating filters that fit your own income and quality criteria. Use our flexible Screener to combine dividend strength, balance sheet quality and risk checks, or tap into our curated Investing Ideas for ready made starting points.
Accenture (ACN)
Accenture helps large companies and governments redesign how they work using consulting, cloud, data, AI and outsourced operations, as well as designing and assembling hardware like robotics and automation equipment. It generates most of its revenue from its Products segment at about US$22.3b, followed by Health & Public Service at US$14.9b, Financial Services at US$13.8b, Communications, Media & Technology at US$12.4b and Resources at US$9.8b. The stock is a global large cap with a market value of roughly US$110.2b.
Income investors may find Accenture interesting because it combines a 3.65% dividend yield with a long track record of serving mission critical clients in areas like financial services, healthcare and government, all while leaning hard into AI partnerships and acquisitions. At the same time, earnings growth has been modest, recent profit margins have eased and a relatively new management team is reshaping a workforce of almost 800,000 people for an AI heavy future. With the stock trading on a lower P/E than the broader US market and IT sector, yet still carrying execution and funding risks, the real question is whether you view today’s discounted valuation and buyback activity as compensation for those uncertainties or as a reason to remain cautious for longer.
Accenture’s lower P/E and heavier AI focus could be masking where the real upside sits. Before the story moves on, read the analyst forecasts for Accenture to see what expectations the market may be missing.
Kaspi.kz (KSPI)
Kaspi.kz runs a super app that combines payments, shopping and fintech services for consumers and merchants across Kazakhstan, Azerbaijan and Ukraine, with a market value of about US$18.9b. The Kaspi.kz app lets users pay everyday bills, send money, shop online or in store and book travel, while merchants use it to accept payments, manage invoices and access financing.
Kaspi.kz sits at the center of digital commerce in Kazakhstan, with its payments, marketplace and fintech platforms feeding off each other to lift user engagement and cross selling. Forecast double digit revenue and earnings growth, a high return on equity and a Q2 dividend uplift signal a business still building out its ecosystem, yet recent margin compression, reliance on external borrowing and insider selling mean you are not being paid a growing income stream without taking funding and execution risk. The key question is whether the super app model and push into Turkey can offset those pressures and support that higher yield over time.
Kaspi.kz’s ecosystem story is accelerating, yet the real twist lies in how growth, margins and funding risk all fit together. Before the narrative moves again, read the full narrative for Kaspi.kz
Curious About What You Might Be Missing
Fresh stock ideas do not stay under the radar for long. Some are building quiet breakout momentum while others are dropping into better value ranges. Act now.
- Spot potential early leaders in fast changing tech and automation by scanning our curated 55 AI infrastructure stocks while the best opportunities are still flying under most investors' screens.
- Hunt for companies quietly compounding value with the list of solid balance sheet and fundamentals (20 results) before the crowd fully prices in their resilient cash flows and financial strength.
- Position ahead of the next metals upcycle by checking the hand picked 9 top copper producer stocks while these producers remain under the radar for now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
